机译：P2Y12抑制剂单药治疗对经皮冠状动脉介入的患者心血管事件的影响智能选择随机临床试验
Wonkwang Univ Hosp Reg Cardiocerebrovasc Ctr Dept Cardiovasc Med Iksan South Korea;
Eulji Gen Hosp Seoul South Korea;
Sungkyunkwan Univ Sch Med Samsung Med Ctr Div Cardiol Dept Med Seoul South Korea;
Catholic Univ St Pauls Hosp Seoul South Korea;
Gwangju Vet Hosp Gwangju South Korea;
Gwangju Vet Hosp Gwangju South Korea;
Natl Hlth Insurance Serv Ilsan Hosp Goyang South Korea;
Eulji Gen Hosp Seoul South Korea;
Daegu Catholic Univ Med Ctr Daegu South Korea;
Dong A Univ Hosp Busan South Korea;
Seoul Natl Univ Bundang Hosp Seongnam South Korea;
Seoul Natl Univ Boramae Med Ctr Seoul South Korea;
Seoul Natl Univ Boramae Med Ctr Seoul South Korea;
Soonchunhyang Univ Cheonan Hosp Cheonan South Korea;
SAM Med Ctr Anyang South Korea;
Yeungnam Univ Hosp Daegu South Korea;
Ulsan Univ Hosp Ulsan South Korea;
Ulsan Univ Hosp Ulsan South Korea;
Gangneung Asan Hosp Kangnung South Korea;
Wonkwang Univ Hosp Iksan South Korea;
Inje Univ Ilsan Paik Hosp Goyang South Korea;
Chonbuk Natl Univ Hosp Jeonju South Korea;
Chosun Univ Hosp Dept Internal Med Gwangju South Korea;
Cheongju St Marys Hosp Cheongju South Korea;
Jeju Natl Univ Hosp Jeju South Korea;
Korea Univ Anam Hosp Seoul South Korea;
Samsung Med Ctr Seoul South Korea;
Aju Univ Hosp Suwon South Korea;
Kunkuk Univ Hosp Seoul South Korea;
Severance Hosp Seoul South Korea;
Sungkyunkwan Univ Sch Med Samsung Med Ctr Seoul South Korea;
机译：P2Y12抑制剂单药治疗对经皮冠状动脉介入的患者心血管事件的影响智能选择随机临床试验
机译：P2Y12抑制剂单疗法与双抗血小板治疗植入冠状动脉洗脱支架患者的比较理由和设计（智能选择）：一种潜在的多中心随机试验
机译：缩写双抗血小板疗法，其次是P2Y（12）抑制剂单疗法与12个月的双抗血小板治疗术后经皮冠状动脉干预后：随机对照试验的系统审查和荟萃分析
机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
机译：围手术期神经肌肉电刺激对心血管手术患者的影响：一项随机对照试验
机译：基于血小板功能测试的经皮冠状动脉介入治疗患者的个体化双重抗血小板治疗：随机对照试验的荟萃分析
机译：P2Y12抑制剂单药治疗对经皮冠状动脉介入患者心血管事件的影响
